Galmed Pharmaceuticals (GLMD) Shareholder's Equity (2013 - 2025)
Galmed Pharmaceuticals (GLMD) Shareholder's Equity (2013 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Shareholder's Equity (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
7.14 Bn |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
795.79 Mn |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
595,226.00 |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
1.00 Bn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
14.38 Mn |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
19.36 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
502.95 Mn |
| 10 |
Galmed Pharmaceuticals |
2.48 Mn |
-1.63 Mn |
- |
15.78 Mn |
| Date | Value |
|---|
| Dec 31, 2025 |
15.78 Mn |
| Dec 31, 2024 |
16.33 Mn |
| Dec 31, 2023 |
13.88 Mn |
| Dec 31, 2022 |
13.42 Mn |
| Dec 31, 2021 |
30.50 Mn |
| Dec 31, 2020 |
44.15 Mn |
| Sep 30, 2020 |
53.66 Mn |
| Jun 30, 2020 |
59.88 Mn |
| Mar 31, 2020 |
64.10 Mn |
| Dec 31, 2019 |
69.85 Mn |
| Sep 30, 2019 |
77.42 Mn |
| Jun 30, 2019 |
81.39 Mn |
| Mar 31, 2019 |
84.93 Mn |
| Dec 31, 2018 |
87.89 Mn |
| Sep 30, 2018 |
90.75 Mn |
| Jun 30, 2018 |
91.04 Mn |
| Mar 31, 2018 |
13.60 Mn |
| Dec 31, 2017 |
15.80 Mn |
| Sep 30, 2017 |
6.53 Mn |
| Jun 30, 2017 |
6.24 Mn |
